Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-03

Clinical Trial Update: Vaginal Cuff Infiltration With Liposomal Bupivacaine for Pain Relief: A Double Blind, Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial evaluating vaginal cuff infiltration with liposomal bupivacaine for postoperative pain relief has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Olivia Sher | Conditions: Postoperative Pain | Phase 4 | Status: WITHDRAWN